Breast Cancer Advancements

 

There are a lot of research centers that aim to find newer ways to detect and treat breast cancer.  After all, we can fight against it and there is something that can be done.  Here are a few things we found that we think everyone should be aware of:

Vitamin D

Vitamin D“Sunlight appears to have both direct and indirect effects on breast cancer. The ultraviolet portion of sunlight stimulates the body to produce vitamin D, which protects against breast cancer. Women who spend a moderate amount of time in the sun, especially during midday, may benefit.

Melatonin has been found to be associated with reduced risk of breast cancer. Melatonin is made by the pineal gland, which is connected to the eyes and is sensitive to bright blue light. At night, when there is no bright blue light, melatonin is produced. Melatonin is a hormone that induces sleep and may also reduce the risk of breast cancer. However, during the longer days of summer, the body produces less melatonin. Thus, melatonin seems to help reduce the risk of breast cancer in winter.

The number of breast cancer cases and rate of diagnoses vary with the amount of sunlight and the seasons. According to breast and other cancer studies, there are:

  • Lower rates in the sunny Southwest United States and higher rates in the darker Northeast

  • Higher rates in countries that are further from the equator and receive less sunlight”

Read More.

MammoSite APBI Demonstrates Excellent Cosmesis and Low Local Recurrence

MammoSite Therapy“By employing MammoSite Therapy, the radiation oncologist can deliver targeted radiation therapy directly to the area where cancer is most likely to recur, allowing a full course of radiation to be delivered in just five days as compared to five to seven weeks. Additionally, targeted therapy of the breast limits radiation exposure to normal, healthy tissue minimizing side effects such as skin discoloration, scarring, burning, fatigue and damage to surrounding organs. With its multi-lumen design, the MammoSite ML system gives radiation oncologists the ability to adjust the radiation dose for typical cases and treat patients who are otherwise not appropriate candidates for traditional brachytherapy. First cleared for sale by the FDA in 2002, MammoSite is the most widely utilized and accepted method of APBI in the United States.”

Read More.

Cone-beam breast CT Compared to Conventional Mammography

 cone-beam CT “Cone-beam breast CT employs a large area x-ray beam in conjunction with a flat panel x-ray detector to scan and generate 3D images of the breast. The scanner is placed below a table on which the patient lies prone with the breast protruding through an opening. Only the breast is exposed to radiation resulting in improved image quality and sparing the rest of the patient’s body from unnecessary radiation exposure. The scan can be completed in less than one minute with a single complete rotation of the x-ray tube-detector gantry around the breast. Unlike conventional CT, the patient is not moved through the gantry during scanning.

For the study, the researchers used cone-beam CT on 12 mastectomy specimens. The researchers discovered that structured noise on cone-beam CT was minimal because of the absence of overlapping tissue; that breast anatomy was well resolved on all images as skin, adipose, and glandular regions; and that microcalcifications within cancers were clearly shown. In addition, they discovered that the detection of cancers based on morphologic assessment of tissue structures could potentially be improved compared with mammography because of the lack of overlapping glandular tissue.”

Read More.

The goal of these developments is for us to have more survivors rather victims and as the years pass, there are more researches being done in an effort to eradicate this disease.  This give breast cancer patients and families more options to deal with it and choose one which they are most comfortable in.

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris was born in Europe but has lived in the US for many years. He attended college both in Europe and the US and completed medical school at the University of Texas. Residency and fellowship in oncology was completed at Baylor. Read More...
Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton